Strs Ohio Invests $1.54 Million in The Clorox Company $CLX

Strs Ohio purchased a new position in The Clorox Company (NYSE:CLX) in the first quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor purchased 10,437 shares of the company’s stock, valued at approximately $1,537,000.

A number of other hedge funds have also made changes to their positions in CLX. Wood Tarver Financial Group LLC purchased a new stake in shares of Clorox in the fourth quarter worth approximately $31,000. Ransom Advisory Ltd purchased a new stake in shares of Clorox in the first quarter worth approximately $35,000. GW&K Investment Management LLC lifted its position in shares of Clorox by 239.1% in the first quarter. GW&K Investment Management LLC now owns 295 shares of the company’s stock worth $43,000 after purchasing an additional 208 shares in the last quarter. Roble Belko & Company Inc lifted its position in shares of Clorox by 140.7% in the first quarter. Roble Belko & Company Inc now owns 361 shares of the company’s stock worth $53,000 after purchasing an additional 211 shares in the last quarter. Finally, IMA Advisory Services Inc. acquired a new position in Clorox in the first quarter worth approximately $58,000. 78.53% of the stock is owned by hedge funds and other institutional investors.

Analyst Ratings Changes

A number of research firms recently commented on CLX. JPMorgan Chase & Co. increased their price objective on Clorox from $133.00 to $135.00 and gave the stock a “neutral” rating in a report on Monday, September 8th. Citigroup restated a “neutral” rating and issued a $135.00 price objective (down previously from $140.00) on shares of Clorox in a report on Tuesday, July 15th. Jefferies Financial Group dropped their price objective on Clorox from $167.00 to $145.00 and set a “buy” rating on the stock in a report on Thursday, June 26th. Morgan Stanley dropped their price objective on Clorox from $150.00 to $137.00 and set an “equal weight” rating on the stock in a report on Friday, August 1st. Finally, Wells Fargo & Company dropped their price objective on Clorox from $138.00 to $130.00 and set an “equal weight” rating on the stock in a report on Friday, September 5th. One investment analyst has rated the stock with a Buy rating, eight have given a Hold rating and two have issued a Sell rating to the stock. According to MarketBeat, Clorox currently has an average rating of “Reduce” and a consensus target price of $142.18.

Insider Buying and Selling

In related news, COO Eric H. Reynolds sold 15,041 shares of the firm’s stock in a transaction on Thursday, September 4th. The stock was sold at an average price of $123.78, for a total value of $1,861,774.98. Following the completion of the transaction, the chief operating officer directly owned 54,221 shares of the company’s stock, valued at $6,711,475.38. This trade represents a 21.72% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. 0.57% of the stock is currently owned by company insiders.

Clorox Stock Up 1.6%

CLX opened at $124.79 on Wednesday. The Clorox Company has a 1-year low of $116.53 and a 1-year high of $171.37. The company has a current ratio of 0.84, a quick ratio of 0.57 and a debt-to-equity ratio of 5.15. The stock has a market capitalization of $15.26 billion, a price-to-earnings ratio of 19.14, a P/E/G ratio of 0.99 and a beta of 0.52. The business has a 50 day moving average of $124.22 and a 200-day moving average of $131.86.

Clorox (NYSE:CLX) last posted its quarterly earnings data on Thursday, July 31st. The company reported $2.87 earnings per share for the quarter, beating the consensus estimate of $2.24 by $0.63. Clorox had a return on equity of 377.86% and a net margin of 11.40%.The company had revenue of $1.99 billion during the quarter, compared to analysts’ expectations of $1.94 billion. During the same period in the prior year, the business earned $1.82 earnings per share. Clorox’s revenue for the quarter was up 4.5% compared to the same quarter last year. Clorox has set its FY 2026 guidance at 5.950-6.30 EPS. As a group, sell-side analysts anticipate that The Clorox Company will post 7.15 earnings per share for the current year.

Clorox Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Thursday, November 6th. Investors of record on Wednesday, October 22nd will be given a $1.24 dividend. This represents a $4.96 annualized dividend and a yield of 4.0%. The ex-dividend date of this dividend is Wednesday, October 22nd. Clorox’s dividend payout ratio (DPR) is 76.07%.

About Clorox

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.